CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $45,962,431 | +67.1% | 1,560,164 | +85.0% | 2.90% | +60.9% |
Q2 2023 | $27,506,097 | +120.9% | 843,228 | +138.3% | 1.80% | +126.4% |
Q1 2023 | $12,450,081 | -55.4% | 353,796 | -41.9% | 0.80% | -51.9% |
Q4 2022 | $27,901,173 | +79.6% | 608,930 | +89.9% | 1.66% | +83.2% |
Q3 2022 | $15,539,000 | +23.3% | 320,722 | -0.0% | 0.90% | -13.9% |
Q2 2022 | $12,603,000 | +443.9% | 320,780 | +409.6% | 1.05% | +496.6% |
Q1 2022 | $2,317,000 | -89.1% | 62,944 | -86.4% | 0.18% | -85.8% |
Q4 2021 | $21,166,000 | +38.8% | 464,366 | +8.8% | 1.24% | +36.9% |
Q3 2021 | $15,248,000 | +60.1% | 426,632 | -11.4% | 0.90% | +64.5% |
Q2 2021 | $9,525,000 | +5.1% | 481,323 | +23.5% | 0.55% | +0.7% |
Q1 2021 | $9,065,000 | -14.2% | 389,720 | -23.3% | 0.54% | -13.4% |
Q4 2020 | $10,564,000 | +39.7% | 508,394 | +45.5% | 0.63% | +12.1% |
Q3 2020 | $7,562,000 | +100.3% | 349,296 | +118.0% | 0.56% | +135.7% |
Q2 2020 | $3,776,000 | +57.3% | 160,217 | -24.1% | 0.24% | +9.7% |
Q3 2019 | $2,401,000 | – | 210,992 | – | 0.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 4,989,218 | $47,348,000 | 10.09% |
EcoR1 Capital, LLC | 2,139,697 | $20,306,000 | 8.01% |
Healthcare Value Capital, LLC | 100,000 | $949,000 | 1.15% |
DAFNA Capital Management LLC | 150,000 | $1,424,000 | 1.13% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 151,106 | $1,434,000 | 1.07% |
Avoro Capital Advisors LLC | 503,900 | $4,782,000 | 1.06% |
ACUTA CAPITAL PARTNERS, LLC | 140,969 | $1,338,000 | 0.64% |
Iguana Healthcare Management, LLC | 150,000 | $1,424,000 | 0.58% |
WASATCH ADVISORS LP | 1,746,096 | $16,570,000 | 0.25% |
Virtus ETF Advisers LLC | 29,379 | $279,000 | 0.21% |